The week in review

Semaglutide made the news again, as did the question of whether patients need to sign for PBS items We heard from Professor Gary Wittert from the University of Adelaide on the subject of regulating the compounding of Ozempic; meanwhile we heard from the ABC's Four Corners program that a pharmacist (whose registration includes conditions barring

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Vital role supporting home-based rural care patients
Next Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?